ALK and adenocarcinoma: Yoon et al. (Yoon et al., 2015) exhibited the ability to identify adenocarcinomas with ALK, ROS1, and/or RET fusion phenotypes using CT and PET imaging, achieving a sensitivity of 0.73 and specificity of 0.70.